首页> 外国专利> Assay method and the factor peptide before the imbedding whose factor before the imbedding is new

Assay method and the factor peptide before the imbedding whose factor before the imbedding is new

机译:测定方法和包埋前的因子肽,包埋前的因子是新的

摘要

The present invention relates to assay methods used for detecting the presence of PIF, and to PIF peptides identified using this assay. In particular, the present invention relates to flow cytomery assays for detecting PIF. It is based, at least in part, on the observation that flow cytometry using fluorescently labeled antilymphocyte and anti-platelet antibodies demonstrated an increase in rosette formation in the presence of PIF. It is further based on the observation that flow cytometry demonstrated that monoclonal antibody binding to CD2 decreased in the presence of PIF. The present invention further relates to PIF peptides which, when added to Jurkat cell cultures, have been observed to either (I) decrease binding of anti-CD2 antibody to Jurkat cells; (ii) increase expression of CD2 in Jurkat cells; or (iii) decrease Jurkat cell viability. In additional embodiments, the present invention provides for ELISA assays which detect PIF by determining the effect of a test sample on the binding of anti-CD2 antibody to a CD2 substrate.
机译:本发明涉及用于检测PIF存在的测定方法,并涉及用该测定法鉴定的PIF肽。特别地,本发明涉及用于检测PIF的流式细胞术测定法。这至少部分地基于以下观察:使用荧光标记的抗淋巴细胞和抗血小板抗体的流式细胞术证明在PIF存在下玫瑰花结的形成有所增加。进一步基于该观察,流式细胞术证明在PIF存在下单克隆抗体与CD2的结合降低。本发明进一步涉及PIF肽,当将其加入Jurkat细胞培养物中时,已观察到(I)降低抗CD2抗体与Jurkat细胞的结合。 (ii)增加Jurkat细胞中CD2的表达;或(iii)降低Jurkat细胞活力。在另外的实施方案中,本发明提供了ELISA测定,其通过确定测试样品对抗CD2抗体与CD2底物结合的影响来检测PIF。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号